Cytonus Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cytonus Therapeutics's estimated annual revenue is currently $2.6M per year.
- Cytonus Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Cytonus Therapeutics has 17 Employees.
- Cytonus Therapeutics grew their employee count by 0% last year.
Cytonus Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Business Officer | Reveal Email/Phone |
3 | Director Oncology | Reveal Email/Phone |
4 | Director Intellectual Property | Reveal Email/Phone |
5 | Human Resources Manager | Reveal Email/Phone |
6 | Scientist II | Reveal Email/Phone |
7 | Molecular Biologist | Reveal Email/Phone |
8 | Research Associate I | Reveal Email/Phone |
9 | Research Scientist | Reveal Email/Phone |
10 | Research Associate | Reveal Email/Phone |
Cytonus Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Cytonus Therapeutics?
Cytonus Therapeutics Inc. is a San Diego-based biotech company that has developed a vast platform of proprietary immunotherapeutic products to treat a wide range of medical conditions including cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. Its proprietary Cargocyteâ„¢ technologies are next-generation Biomolecular Delivery Transporterâ„¢ which have numerous medical applications across unmet therapeutic areas. Cargocytesâ„¢ are engineered to safely transport a multiplicity of therapeutic payloads into difficult-to-reach targeted tissues, and can be programmed to deliver selective, potent, and controllable allogeneic therapies.
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 17 | N/A | N/A |
#2 | $1.5M | 17 | N/A | N/A |
#3 | $2.1M | 17 | N/A | N/A |
#4 | $2.6M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |